SET SUMOylation promotes its cytoplasmic retention and induces tau pathology and cognitive impairments
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SET SUMOylation promotes its cytoplasmic retention and induces tau pathology and cognitive impairments
Authors
Keywords
Alzheimer’s disease, SET SUMOylation, PP2A, Tau hyperphosphorylation, Cognitive impairments
Journal
Acta Neuropathologica Communications
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-15
DOI
10.1186/s40478-019-0663-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer’s disease
- (2018) Jian Bao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CK2 Phosphorylating I2PP2A/SET Mediates Tau Pathology and Cognitive Impairment
- (2018) Qing Zhang et al. Frontiers in Molecular Neuroscience
- Why estrogens matter for behavior and brain health
- (2017) Liisa A.M. Galea et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Restoring synaptic plasticity and memory in mouse models of Alzheimer’s disease by PKR inhibition
- (2017) Kyoung-Doo Hwang et al. Molecular Brain
- SUMOylation Is an Inhibitory Constraint that Regulates the Prion-like Aggregation and Activity of CPEB3
- (2015) Bettina Drisaldi et al. Cell Reports
- SUMOylation of ATRIP potentiates DNA damage signaling by boosting multiple protein interactions in the ATR pathway
- (2014) C.-S. Wu et al. GENES & DEVELOPMENT
- SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination
- (2014) Hong-Bin Luo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversal of Neurofibrillary Tangles and Tau-Associated Phenotype in the rTgTauEC Model of Early Alzheimer's Disease
- (2013) M. Polydoro et al. JOURNAL OF NEUROSCIENCE
- Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease
- (2013) Guang Yu et al. NEUROBIOLOGY OF AGING
- SUMO and Alzheimer’s Disease
- (2013) Linda Lee et al. NEUROMOLECULAR MEDICINE
- The role of γ-secretase in hippocampal synaptic transmission and activity-dependent synaptic plasticity
- (2013) YuQing Chen et al. NEUROSCIENCE LETTERS
- Merlin sumoylation is required for its tumor suppressor activity
- (2013) Q Qi et al. ONCOGENE
- Increased NR2A:NR2B ratio compresses long-term depression range and constrains long-term memory
- (2013) Zhenzhong Cui et al. Scientific Reports
- Sumoylation of SAE2 C Terminus Regulates SAE Nuclear Localization
- (2012) Khue Truong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sumoylation inhibits α-synuclein aggregation and toxicity
- (2011) Petranka Krumova et al. JOURNAL OF CELL BIOLOGY
- Mechanisms, regulation and consequences of protein SUMOylation
- (2010) Kevin A. Wilkinson et al. BIOCHEMICAL JOURNAL
- SUMOylation attenuates the aggregation propensity and cellular toxicity of the polyglutamine expanded ataxin-7
- (2009) Alexandre Janer et al. HUMAN MOLECULAR GENETICS
- Memory and Brain Systems: 1969-2009
- (2009) L. R. Squire JOURNAL OF NEUROSCIENCE
- SUMO Modification Regulates BLM and RAD51 Interaction at Damaged Replication Forks
- (2009) Karen J. Ouyang et al. PLOS BIOLOGY
- Sumoylation of amyloid precursor protein negatively regulates Aβ aggregate levels
- (2008) Yu-Qian Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice
- (2008) Kaoru Takahashi et al. NEUROSCIENCE LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now